These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

213 related articles for article (PubMed ID: 30383355)

  • 1. Real-Time Monitoring of NDM-1 Activity in Live Bacterial Cells by Isothermal Titration Calorimetry: A New Approach To Measure Inhibition of Antibiotic-Resistant Bacteria.
    Zhang YJ; Wang WM; Oelschlaeger P; Chen C; Lei JE; Lv M; Yang KW
    ACS Infect Dis; 2018 Dec; 4(12):1671-1678. PubMed ID: 30383355
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Amino Acid Thioesters Exhibit Inhibitory Activity against B1-B3 Subclasses of Metallo-β-lactamases.
    Zhang YJ; Liu XL; Wang WM; Chen C; Zhao MH; Yang KW
    Chem Pharm Bull (Tokyo); 2019; 67(2):135-142. PubMed ID: 30713274
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Real-time activity assays of β-lactamases in living bacterial cells: application to the inhibition of antibiotic-resistant E. coli strains.
    Ge Y; Zhou YJ; Yang KW; Zhang YL; Xiang Y; Zhang YJ
    Mol Biosyst; 2017 Oct; 13(11):2323-2327. PubMed ID: 28906528
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Stereochemically altered cephalosporins as potent inhibitors of New Delhi metallo-β-lactamases.
    Hu L; Yang H; Yu T; Chen F; Liu R; Xue S; Zhang S; Mao W; Ji C; Wang H; Xie H
    Eur J Med Chem; 2022 Mar; 232():114174. PubMed ID: 35152091
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dithiocarbamate as a Valuable Scaffold for the Inhibition of Metallo-β-Lactmases.
    Ge Y; Xu LW; Liu Y; Sun LY; Gao H; Li JQ; Yang K
    Biomolecules; 2019 Nov; 9(11):. PubMed ID: 31694268
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Thiosemicarbazones exhibit inhibitory efficacy against New Delhi metallo-β-lactamase-1 (NDM-1).
    Ge Y; Kang PW; Li JQ; Gao H; Zhai L; Sun LY; Chen C; Yang KW
    J Antibiot (Tokyo); 2021 Sep; 74(9):574-579. PubMed ID: 34234284
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Recent research and development of NDM-1 inhibitors.
    Wang T; Xu K; Zhao L; Tong R; Xiong L; Shi J
    Eur J Med Chem; 2021 Nov; 223():113667. PubMed ID: 34225181
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Structure-guided optimization of D-captopril for discovery of potent NDM-1 inhibitors.
    Ma G; Wang S; Wu K; Zhang W; Ahmad A; Hao Q; Lei X; Zhang H
    Bioorg Med Chem; 2021 Jan; 29():115902. PubMed ID: 33302045
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dihydroxyphenyl-substituted thiosemicarbazone: A potent scaffold for the development of metallo-β-lactamases inhibitors and antimicrobial.
    Liu L; Xu YS; Chigan JZ; Zhai L; Ding HH; Wu XR; Chen WY; Yang KW
    Bioorg Chem; 2022 Oct; 127():105928. PubMed ID: 35717802
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ebsulfur as a potent scaffold for inhibition and labelling of New Delhi metallo-β-lactamase-1 in vitro and in vivo.
    Su J; Liu J; Chen C; Zhang Y; Yang K
    Bioorg Chem; 2019 Mar; 84():192-201. PubMed ID: 30502631
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Characterization of β-lactamase activity using isothermal titration calorimetry.
    Wang WJ; Wang Q; Zhang Y; Lu R; Zhang YL; Yang KW; Lei JE; He Y
    Biochim Biophys Acta Gen Subj; 2017 Aug; 1861(8):2031-2038. PubMed ID: 28454737
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Aromatic Schiff bases confer inhibitory efficacy against New Delhi metallo-β-lactamase-1 (NDM-1).
    Zhai L; Jiang Y; Shi Y; Lv M; Pu YL; Cheng HL; Zhu JY; Yang KW
    Bioorg Chem; 2022 Sep; 126():105910. PubMed ID: 35653899
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Small Molecule Carboxylates Inhibit Metallo-β-lactamases and Resensitize Carbapenem-Resistant Bacteria to Meropenem.
    Tehrani KHME; Brüchle NC; Wade N; Mashayekhi V; Pesce D; van Haren MJ; Martin NI
    ACS Infect Dis; 2020 Jun; 6(6):1366-1371. PubMed ID: 32227874
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Discovery of hydroxamate as a promising scaffold dually inhibiting metallo- and serine-β-lactamases.
    Wu XR; Chen WY; Liu L; Yang KW
    Eur J Med Chem; 2024 Feb; 265():116055. PubMed ID: 38134748
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Azetidinimines as a novel series of non-covalent broad-spectrum inhibitors of β-lactamases with submicromolar activities against carbapenemases KPC-2 (class A), NDM-1 (class B) and OXA-48 (class D).
    Romero E; Oueslati S; Benchekroun M; D'Hollander ACA; Ventre S; Vijayakumar K; Minard C; Exilie C; Tlili L; Retailleau P; Zavala A; Elisée E; Selwa E; Nguyen LA; Pruvost A; Naas T; Iorga BI; Dodd RH; Cariou K
    Eur J Med Chem; 2021 Jul; 219():113418. PubMed ID: 33862516
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Diaryl-substituted thiosemicarbazone: A potent scaffold for the development of New Delhi metallo-β-lactamase-1 inhibitors.
    Li JQ; Sun LY; Jiang Z; Chen C; Gao H; Chigan JZ; Ding HH; Yang KW
    Bioorg Chem; 2021 Feb; 107():104576. PubMed ID: 33383326
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Potential inhibitors designed against NDM-1 type metallo-β-lactamases: an attempt to enhance efficacies of antibiotics against multi-drug-resistant bacteria.
    Khan AU; Ali A; Danishuddin ; Srivastava G; Sharma A
    Sci Rep; 2017 Aug; 7(1):9207. PubMed ID: 28835636
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dipicolinic Acid Derivatives as Inhibitors of New Delhi Metallo-β-lactamase-1.
    Chen AY; Thomas PW; Stewart AC; Bergstrom A; Cheng Z; Miller C; Bethel CR; Marshall SH; Credille CV; Riley CL; Page RC; Bonomo RA; Crowder MW; Tierney DL; Fast W; Cohen SM
    J Med Chem; 2017 Sep; 60(17):7267-7283. PubMed ID: 28809565
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The assemblage of covalent and metal binding dual functional scaffold for cross-class metallo-β-lactamases inhibition.
    Chen C; Liu Y; Zhang YJ; Ge Y; Lei JE; Yang KW
    Future Med Chem; 2019 Sep; 11(18):2381-2394. PubMed ID: 31544522
    [No Abstract]   [Full Text] [Related]  

  • 20. Azolylthioacetamides as a potent scaffold for the development of metallo-β-lactamase inhibitors.
    Xiang Y; Chang YN; Ge Y; Kang JS; Zhang YL; Liu XL; Oelschlaeger P; Yang KW
    Bioorg Med Chem Lett; 2017 Dec; 27(23):5225-5229. PubMed ID: 29122480
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.